US 12178787
T cell receptors for immunotherapy
granted A61KA61K2239/57A61K31/675
Quick answer
US patent 12178787 (T cell receptors for immunotherapy) held by The Board of Regents of the University of Texas System expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2239/57, A61K31/675, A61K31/7076, A61K40/11